| |
 |
|
|
|
|
| Meiji Seika Subsidiary Receives Sales Approval for "MEIACT" in Spain |
|
|
|
Tokyo, Apr 27, 2004 (JCN) - Meiji Seika (TSE: 2202) has announced that its consolidated subsidiary Tedec-Meiji Farma SA has received sales approval for "MEIACT," oral cephalosporin antibiotic, in Spain.
Tedec-Meiji plans to begin marketing the product after the third-quarter of 2004. Meiji owns 80% of the Spanish subsidiary, which had sales of 39.6 million euros in 2003.
Copyright © 2013 JCN. All rights reserved. A division of Japan Corporate News Network KK.
 Company Profile |  Print |  Alerts
|
|
|
(Update) Meiji Dairies, Meiji Seika to Integrate Biz
(Sept 12, 2008)
|
|
|
Meiji Seika Kaisha, Solvay Seiyaku Obtain Additional Approval for Fluvoxamine Maleate
(Oct 14, 2005)
|
|
|
Meiji Seika Kaisha to Market New Antiaging Supplement
(Sept 16, 2005)
|
|
|
Dainippon Pharmaceutical, Meiji Seika Kaisha Jointly Market New Formulations for Ebastel Antiallergic Agent
(July 11, 2005)
|
|
|
Meiji Seika Kaisha Confirms Perilla-derived Rosmarinic Acid's Effectiveness Against Hay Fever
(Feb 28, 2005)
|
|
|
Meiji Seika Kaisha Releases New Oral Cephem Antibiotic for Pediatric Use
(Aug 9, 2004)
|
|
|
Nippon Organon Licenses Antidepressant to Meiji Seika Kaisha
(Aug 5, 2004)
|
|
|
Meiji Seika to Introduce New PDT Drug for Early Lung Cancer Treatment
(June 25, 2004)
|
|
|
Meiji Seika Subsidiary Receives Sales Approval for "MEIACT" in Spain
(Apr 27, 2004)
|
|
|
Combination of Antioxidant Substance and Oligosaccharide May Prevent Lifestyle-related Diseases: Meiji Seika Kaisha
(Mar 30, 2004)
|
|
|
|
|
|
|
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
|
|
|
Teijin Launches Polyester Curtain Fabric with Enhanced Pollen-trapping (Feb 21, 2013)
|
|
|
Toyota Tsusho Opens Medical Clinic in Thai Plant (Feb 18, 2013)
|
|
|
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
|
|
|
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
|
|
|
Teijin and InCube Labs Enter Strategic Partnership in Healthcare Business (Jan 22, 2013)
|
|
|
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
|
|
|
Takara Bio Initiates Phase 1 HIV Gene Therapy Clinical Trial (Jan 7, 2013)
|
|
|
Kobe University, KNC Labs and Dainippon Sumitomo to Research Anti-cancer Agent (Dec 28, 2012)
|
|
|
Daiichi Sankyo Introduces Alzheimer's Disease Awareness Campaign (Dec 20, 2012)
|
More Drugs & OTC news...
|
|
|
|
|
|
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
|
|
|
Teijin Launches Polyester Curtain Fabric with Enhanced Pollen-trapping (Feb 21, 2013)
|
|
|
Toyota Tsusho Opens Medical Clinic in Thai Plant (Feb 18, 2013)
|
|
|
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
|
|
|
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
|
|
|
Teijin and InCube Labs Enter Strategic Partnership in Healthcare Business (Jan 22, 2013)
|
|
|
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
|
|
|
Takara Bio Initiates Phase 1 HIV Gene Therapy Clinical Trial (Jan 7, 2013)
|
|
|
Kobe University, KNC Labs and Dainippon Sumitomo to Research Anti-cancer Agent (Dec 28, 2012)
|
|
|
Daiichi Sankyo Introduces Alzheimer's Disease Awareness Campaign (Dec 20, 2012)
|
More Drugs & OTC news...
|
|
|
|
|
|
|
|
|
|
